Harvard Historical Financial Ratios

HBIO Stock

USD 2.20 0.01 0.46%

Harvard Bioscience is recently reporting on over 112 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as PTB Ratio of 4.65 or Days Sales Outstanding of 73.28 will help investors to properly organize and evaluate Harvard Bioscience financial condition quickly.

Quick Ratio Current Ratio

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Harvard Bioscience. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.

To learn how to invest in Harvard Stock, please use our How to Invest in Harvard Bioscience guide.

About Harvard Financial Ratios Analysis

Harvard BioscienceFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Harvard Bioscience investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Harvard financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Harvard Bioscience history.

Harvard Bioscience Financial Ratios Chart

At this time, Harvard Bioscience's Inventory Turnover is very stable compared to the past year. As of the 29th of November 2024, Sales General And Administrative To Revenue is likely to grow to 0.25, while Price To Sales Ratio is likely to drop 1.72.

Dividend Yield Ptb Ratio Stock Based Compensation To Revenue Pocfratio Roe Return On Assets

Add Fundamental

Dividend Yield

Dividend Yield is Harvard Bioscience dividend as a percentage of Harvard Bioscience stock price. Harvard Bioscience dividend yield is a measure of Harvard Bioscience stock productivity, which can be interpreted as interest rate earned on an Harvard Bioscience investment. A financial ratio that shows how much a company pays out in dividends each year relative to its stock price, calculated as annual dividends per share divided by price per share.

Ptb Ratio

Price-to-Book ratio, a financial valuation metric used to compare a company's current market price to its book value. It provides insight into the value that market participants place on the company's equity relative to its net asset value.

Stock Based Compensation To Revenue

A metric that compares the total value of stock-based compensation granted by a company to its total revenue, indicating how much of the revenue is used to compensate employees with stock options or awards.

Return On Assets

A profitability ratio that indicates the percentage of profit a company earns in relation to its overall resources. It is calculated by dividing net income by total assets.

Most ratios from Harvard Bioscience's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Harvard Bioscience current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Harvard Bioscience. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.

To learn how to invest in Harvard Stock, please use our How to Invest in Harvard Bioscience guide.At this time, Harvard Bioscience's Inventory Turnover is very stable compared to the past year. As of the 29th of November 2024, Sales General And Administrative To Revenue is likely to grow to 0.25, while Price To Sales Ratio is likely to drop 1.72.

	2023	2024 (projected)
Dividend Yield	0.002551	0.002218
Price To Sales Ratio	2.02	1.72

Dividend Yield Price To Sales Ratio

Harvard Bioscience fundamentals Correlations

	Price To Sales Ratio	Dividend Yield	Ptb Ratio	Days Sales Outstanding	Book Value Per Share	Free Cash Flow Yield	Operating Cash Flow Per Share	Capex To Depreciation	Pb Ratio	Ev To Sales	Free Cash Flow Per Share	Roic	Inventory Turnover	Net Income Per Share	Days Of Inventory On Hand	Payables Turnover	Average Inventory	Capex To Revenue	Cash Per Share	Pocfratio	Interest Coverage	Payout Ratio	Capex To Operating Cash Flow	Pfcf Ratio	Days Payables Outstanding	Income Quality
Price To Sales Ratio		-0.31	0.82	0.19	-0.71	0.16	0.59	-0.13	0.82	0.97	0.59	0.8	0.33	0.18	-0.11	-0.39	-0.6	0.0	-0.29	0.06	-0.54	-0.57	-0.18	-0.33	0.42	-0.33
Dividend Yield	-0.31		-0.14	-0.41	0.06	-0.33	-0.38	-0.13	-0.14	-0.27	-0.37	-0.21	-0.13	-0.04	0.13	0.4	0.9	-0.35	0.35	0.27	0.1	-0.27	0.22	-0.09	-0.33	0.5
Ptb Ratio	0.82	-0.14		0.09	-0.73	0.28	0.7	-0.1	1.0	0.74	0.69	0.9	0.63	0.16	-0.44	-0.36	-0.55	-0.1	-0.18	-0.17	-0.68	-0.87	-0.16	0.03	0.44	0.06
Days Sales Outstanding	0.19	-0.41	0.09		0.1	0.36	0.22	-0.24	0.09	0.21	0.25	0.23	0.14	0.13	-0.12	-0.19	-0.42	-0.15	0.06	-0.12	0.05	-0.05	-0.29	-0.36	0.14	-0.27
Book Value Per Share	-0.71	0.06	-0.73	0.1		0.0	-0.37	0.42	-0.73	-0.78	-0.4	-0.5	-0.01	0.24	-0.19	0.63	0.34	0.18	0.67	-0.1	0.88	0.57	-0.02	0.11	-0.66	0.32
Free Cash Flow Yield	0.16	-0.33	0.28	0.36	0.0		0.84	-0.15	0.28	0.11	0.86	0.48	0.34	0.5	-0.3	0.05	-0.39	-0.14	0.17	-0.81	0.07	-0.1	-0.72	0.27	-0.07	0.11
Operating Cash Flow Per Share	0.59	-0.38	0.7	0.22	-0.37	0.84		-0.03	0.7	0.5	0.99	0.78	0.55	0.38	-0.41	-0.2	-0.6	0.03	0.05	-0.68	-0.27	-0.43	-0.54	0.25	0.24	0.08
Capex To Depreciation	-0.13	-0.13	-0.1	-0.24	0.42	-0.15	-0.03		-0.1	-0.29	-0.14	-0.17	0.4	-0.21	-0.5	0.05	-0.07	0.87	0.37	0.02	0.26	0.13	0.49	0.23	-0.01	0.34
Pb Ratio	0.82	-0.14	1.0	0.09	-0.73	0.28	0.7	-0.1		0.74	0.69	0.9	0.63	0.16	-0.44	-0.36	-0.55	-0.1	-0.18	-0.17	-0.68	-0.87	-0.16	0.03	0.44	0.06
Ev To Sales	0.97	-0.27	0.74	0.21	-0.78	0.11	0.5	-0.29	0.74		0.52	0.7	0.11	0.1	0.12	-0.48	-0.52	-0.08	-0.42	0.12	-0.56	-0.49	-0.17	-0.4	0.49	-0.43
Free Cash Flow Per Share	0.59	-0.37	0.69	0.25	-0.4	0.86	0.99	-0.14	0.69	0.52		0.79	0.5	0.42	-0.35	-0.19	-0.59	-0.08	0.01	-0.69	-0.28	-0.42	-0.62	0.24	0.22	0.03
Roic	0.8	-0.21	0.9	0.23	-0.5	0.48	0.78	-0.17	0.9	0.7	0.79		0.66	0.53	-0.48	-0.1	-0.56	-0.24	0.05	-0.33	-0.36	-0.74	-0.47	0.01	0.16	0.05
Inventory Turnover	0.33	-0.13	0.63	0.14	-0.01	0.34	0.55	0.4	0.63	0.11	0.5	0.66		0.33	-0.96	0.12	-0.42	0.13	0.47	-0.4	-0.18	-0.65	-0.17	0.33	-0.04	0.38
Net Income Per Share	0.18	-0.04	0.16	0.13	0.24	0.5	0.38	-0.21	0.16	0.1	0.42	0.53	0.33		-0.29	0.57	-0.1	-0.45	0.43	-0.39	0.4	-0.13	-0.79	-0.07	-0.6	0.19
Days Of Inventory On Hand	-0.11	0.13	-0.44	-0.12	-0.19	-0.3	-0.41	-0.5	-0.44	0.12	-0.35	-0.48	-0.96	-0.29		-0.18	0.35	-0.18	-0.51	0.42	0.04	0.5	0.12	-0.43	0.11	-0.45
Payables Turnover	-0.39	0.4	-0.36	-0.19	0.63	0.05	-0.2	0.05	-0.36	-0.48	-0.19	-0.1	0.12	0.57	-0.18		0.49	-0.28	0.71	0.01	0.59	0.16	-0.25	-0.05	-0.98	0.26
Average Inventory	-0.6	0.9	-0.55	-0.42	0.34	-0.39	-0.6	-0.07	-0.55	-0.52	-0.59	-0.56	-0.42	-0.1	0.35	0.49		-0.23	0.35	0.3	0.38	0.18	0.24	-0.1	-0.47	0.36
Capex To Revenue	0.0	-0.35	-0.1	-0.15	0.18	-0.14	0.03	0.87	-0.1	-0.08	-0.08	-0.24	0.13	-0.45	-0.18	-0.28	-0.23		0.06	0.09	0.1	0.28	0.57	0.11	0.3	0.04
Cash Per Share	-0.29	0.35	-0.18	0.06	0.67	0.17	0.05	0.37	-0.18	-0.42	0.01	0.05	0.47	0.43	-0.51	0.71	0.35	0.06		-0.26	0.59	-0.02	-0.17	0.12	-0.65	0.5
Pocfratio	0.06	0.27	-0.17	-0.12	-0.1	-0.81	-0.68	0.02	-0.17	0.12	-0.69	-0.33	-0.4	-0.39	0.42	0.01	0.3	0.09	-0.26		-0.08	0.04	0.7	-0.69	0.01	-0.26
Interest Coverage	-0.54	0.1	-0.68	0.05	0.88	0.07	-0.27	0.26	-0.68	-0.56	-0.28	-0.36	-0.18	0.4	0.04	0.59	0.38	0.1	0.59	-0.08		0.59	-0.14	-0.02	-0.63	0.29
Payout Ratio	-0.57	-0.27	-0.87	-0.05	0.57	-0.1	-0.43	0.13	-0.87	-0.49	-0.42	-0.74	-0.65	-0.13	0.5	0.16	0.18	0.28	-0.02	0.04	0.59		0.04	-0.01	-0.27	-0.33
Capex To Operating Cash Flow	-0.18	0.22	-0.16	-0.29	-0.02	-0.72	-0.54	0.49	-0.16	-0.17	-0.62	-0.47	-0.17	-0.79	0.12	-0.25	0.24	0.57	-0.17	0.7	-0.14	0.04		-0.13	0.31	0.07
Pfcf Ratio	-0.33	-0.09	0.03	-0.36	0.11	0.27	0.25	0.23	0.03	-0.4	0.24	0.01	0.33	-0.07	-0.43	-0.05	-0.1	0.11	0.12	-0.69	-0.02	-0.01	-0.13		0.09	0.4
Days Payables Outstanding	0.42	-0.33	0.44	0.14	-0.66	-0.07	0.24	-0.01	0.44	0.49	0.22	0.16	-0.04	-0.6	0.11	-0.98	-0.47	0.3	-0.65	0.01	-0.63	-0.27	0.31	0.09		-0.18
Income Quality	-0.33	0.5	0.06	-0.27	0.32	0.11	0.08	0.34	0.06	-0.43	0.03	0.05	0.38	0.19	-0.45	0.26	0.36	0.04	0.5	-0.26	0.29	-0.33	0.07	0.4	-0.18

Click cells to compare fundamentals

Harvard Bioscience Account Relationship Matchups

Harvard Bioscience fundamentals Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Price To Sales Ratio	0.99	1.62	2.39	1.01	2.02	1.72
Ptb Ratio	1.41	2.16	3.41	1.59	3.11	4.65
Days Sales Outstanding	65.05	63.51	67.02	53.8	52.35	73.28
Book Value Per Share	2.16	1.98	2.07	1.74	1.72	2.85
Free Cash Flow Yield	0.0592	0.0493	(2.92E-4)	(0.003818)	0.0516	0.0501
Operating Cash Flow Per Share	0.0654	0.21	0.24	0.0313	0.0278	0.33
Stock Based Compensation To Revenue	0.0261	0.0357	0.0351	0.0389	0.0445	0.0423
Capex To Depreciation	0.16	0.15	0.18	0.21	0.33	0.4
Pb Ratio	1.41	2.16	3.41	1.59	3.11	4.65
Free Cash Flow Per Share	0.18	0.21	(0.002057)	(0.0106)	0.28	0.19
Roic	0.009254	(0.005025)	0.0219	(0.0624)	0.0228	0.0301
Inventory Turnover	2.35	1.98	1.86	1.99	1.87	3.15
Net Income Per Share	(0.12)	(0.2)	(0.007139)	(0.23)	(0.0805)	(0.0845)
Days Of Inventory On Hand	155.29	184.43	196.47	183.76	195.36	110.58
Payables Turnover	9.71	7.38	10.44	8.15	8.31	7.07
Research And Ddevelopement To Revenue	0.091	0.0922	0.0851	0.0908	0.11	0.1
Capex To Revenue	0.008164	0.0105	0.0113	0.014	0.0206	0.0195
Pocfratio	14.33	17.77	225.37	99.58	16.18	15.37
Interest Coverage	0.27	(0.12)	0.91	(3.19)	0.53	0.55
Capex To Operating Cash Flow	0.42	0.15	0.12	1.07	1.38	0.16
Pfcf Ratio	16.88	20.27	(3.4K)	(261.9)	19.37	20.34
Days Payables Outstanding	37.58	49.47	34.97	44.81	43.9	47.73
Income Quality	(1.72)	(1.19)	(4.38)	(0.12)	(4.11)	(3.9)
Roe	(0.0574)	(0.1)	(0.003453)	(0.13)	(0.0467)	(0.0491)
Ev To Operating Cash Flow	19.98	22.02	257.47	136.31	18.92	17.98
Pe Ratio	(24.61)	(21.22)	(987.56)	(12.05)	(66.46)	(63.13)
Return On Tangible Assets	(0.0678)	(0.12)	(0.003727)	(0.14)	(0.0531)	(0.0558)
Ev To Free Cash Flow	23.54	25.12	(3.9K)	(358.52)	22.65	23.79
Earnings Yield	(0.0406)	(0.0471)	(0.001013)	(0.083)	(0.015)	(0.0158)
Net Debt To E B I T D A	6.06	7.23	3.58	44.83	4.79	5.03
Current Ratio	2.12	2.46	2.43	2.2	1.85	1.76
Tangible Book Value Per Share	(0.37)	(0.39)	(0.0415)	(0.12)	(6.36E-4)	(6.05E-4)
Receivables Turnover	5.61	5.75	5.45	6.78	6.97	4.51

When determining whether Harvard Bioscience offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Harvard Bioscience's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Harvard Bioscience Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Harvard Bioscience Stock:

How To Invest In Harvard

Details

Is Harvard Stock a good investment?

Details

What is Harvard Bioscience's Net Worth?

Details

Largest Life Sciences Tools & Services Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

To learn how to invest in Harvard Stock, please use our How to Invest in Harvard Bioscience guide.

You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.

Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Harvard Bioscience. If investors know Harvard will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Harvard Bioscience listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.80)

Earnings Share

(0.33)

Revenue Per Share

2.258

Quarterly Revenue Growth

(0.13)

Return On Assets

(0.02)

The market value of Harvard Bioscience is measured differently than its book value, which is the value of Harvard that is recorded on the company's balance sheet. Investors also form their own opinion of Harvard Bioscience's value that differs from its market value or its book value, called intrinsic value, which is Harvard Bioscience's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Harvard Bioscience's market value can be influenced by many factors that don't directly affect Harvard Bioscience's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Harvard Bioscience's value and its price as these two are different measures arrived at by different means. Investors typically determine if Harvard Bioscience is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Harvard Bioscience's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Price To Sales Ratio	Dividend Yield
Ptb Ratio	Days Sales Outstanding
Book Value Per Share	Free Cash Flow Yield
Invested Capital	Operating Cash Flow Per Share
Average Payables	Stock Based Compensation To Revenue
Capex To Depreciation	Pb Ratio
Ev To Sales	Free Cash Flow Per Share
Roic	Inventory Turnover
Net Income Per Share	Days Of Inventory On Hand
Payables Turnover	Sales General And Administrative To Revenue
Average Inventory	Research And Ddevelopement To Revenue
Capex To Revenue	Cash Per Share
Pocfratio	Interest Coverage
Payout Ratio	Capex To Operating Cash Flow
Pfcf Ratio	Days Payables Outstanding
Net Current Asset Value	Income Quality
Roe	Tangible Asset Value
Ev To Operating Cash Flow	Pe Ratio
Return On Tangible Assets	Ev To Free Cash Flow
Earnings Yield	Intangibles To Total Assets
Net Debt To E B I T D A	Current Ratio
Tangible Book Value Per Share	Receivables Turnover
Graham Number	Shareholders Equity Per Share
Debt To Equity	Capex Per Share
Graham Net Net	Average Receivables
Revenue Per Share	Interest Debt Per Share
Debt To Assets	Enterprise Value Over E B I T D A
Short Term Coverage Ratios	Price Earnings Ratio
Operating Cycle	Price Book Value Ratio
Price Earnings To Growth Ratio	Days Of Payables Outstanding
Dividend Payout Ratio	Price To Operating Cash Flows Ratio
Price To Free Cash Flows Ratio	Pretax Profit Margin
Ebt Per Ebit	Operating Profit Margin
Effective Tax Rate	Company Equity Multiplier
Long Term Debt To Capitalization	Total Debt To Capitalization
Return On Capital Employed	Debt Equity Ratio
Ebit Per Revenue	Quick Ratio
Dividend Paid And Capex Coverage Ratio	Net Income Per E B T
Cash Ratio	Cash Conversion Cycle
Operating Cash Flow Sales Ratio	Days Of Inventory Outstanding
Days Of Sales Outstanding	Free Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage Ratios	Price To Book Ratio
Fixed Asset Turnover	Capital Expenditure Coverage Ratio
Price Cash Flow Ratio	Enterprise Value Multiple
Debt Ratio	Cash Flow To Debt Ratio
Price Sales Ratio	Return On Assets
Asset Turnover	Net Profit Margin
Gross Profit Margin	Price Fair Value
Return On Equity

Harvard Historical Financial Ratios

About Harvard Financial Ratios Analysis

Harvard Bioscience Financial Ratios Chart

Dividend Yield

Ptb Ratio

Stock Based Compensation To Revenue

Return On Assets

Harvard Bioscience fundamentals Correlations

Harvard Bioscience Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Harvard Bioscience fundamentals Accounts

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Pb Ratio	+ 1.0	Ptb Ratio
Free Cash Flow Per Share	+ 0.99	Operating Cash Flow Per Share
Ev To Sales	+ 0.97	Price To Sales Ratio
Average Inventory	+ 0.9	Dividend Yield
Roic	+ 0.9	Ptb Ratio
Roic	+ 0.9	Pb Ratio

Days Payables Outstanding	- 0.98	Payables Turnover
Days Of Inventory On Hand	- 0.96	Inventory Turnover
Payout Ratio	- 0.87	Pb Ratio
Payout Ratio	- 0.87	Ptb Ratio
Pocfratio	- 0.81	Free Cash Flow Yield
Capex To Operating Cash Flow	- 0.79	Net Income Per Share